 |
Turna Ray is the editor of GenomeWeb's Pharmacogenomics Reporter. She covers pharmacogenomics, personalized medicine, and companion diagnostics. E-mail Turna Ray or follow her GenomeWeb Twitter account at @PGxReporter. |
In a Customer Subset, 23andMe Finds No Emotional Distress from Knowledge of BRCA Mutation Status
February 20, 2013
In a Customer Subset, 23andMe Finds No Emotional Distress from Knowledge of BRCA Mutation Status
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- 2010 in Review: Genomic Medicine Experiences Growing Pains of Regulation, Economics, and Litigation
January 12, 2011 / Pharmacogenomics Reporter - UC Berkeley Fends off DTC Genomics Critics; Other Schools Mull Genetic Tests as Educational Tools
May 26, 2010 / Pharmacogenomics Reporter - GenomeWeb Feature: Will the Future of Genomics be Consumer Driven?
March 4, 2013 / GenomeWeb Daily News - With Decode Purchase, Amgen Gains Genetics Expertise, Consumers Lose DTC Testing Option
December 12, 2012 / Pharmacogenomics Reporter - Federal Circuit Judges Considered USPTO Policy, Industry Impact in Ruling on Myriad's Gene Patents
August 22, 2012 / Pharmacogenomics Reporter